(Recasts first paragraph, adds virus details, Creon revenues) By Susan Heavey WASHINGTON, Nov 28 (Reuters) - U.S. health regulators are concerned about the risk of patients contracting viruses from ...
WASHINGTON, May 1 (Reuters) - U.S. health officials have formally approved Solvay SA's enzyme drug Creon for adults and children with a digestive disorder resulting from conditions such as cystic ...
Creon is a brand-name prescription medication that can treat exocrine pancreatic insufficiency (EPI). The cost of Creon through Medicare may vary depending on many factors, such as a person’s ...
Creon (pancrelipase) is a medication used to treat exocrine pancreatic insufficiency (EPI), a condition in which your pancreas doesn’t produce enough enzymes for you to digest your food. Medicare ...
Nearly all UK pharmacies are experiencing severe “challenges” supplying pancreatic enzyme replacement therapy (PERT), the National Pharmacy Association (NPA) warned. A sample survey by the association ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results